Haemonetics Corporation

NYSE:HAE

71.48 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991
Revenue 1,309.0551,168.66993.196870.463988.479967.579903.923886.116909.675910.373938.509891.99727.844676.694645.43597.879516.44449.607419.733383.598364.229336.956319.969293.86277.924282.1285.8309.8278.2262.4248.4216.3176.4157.3
Cost of Revenue 632.518553.563487.694472.625503.966550.043492.015507.622503.802475.955470.144463.859358.604321.485307.949289.709258.715222.307199.198185.722192.109182.26165.135126.948121.7124127.1137.8110.5103.994.288.878.50
Gross Profit 676.537615.097505.502397.838484.513417.536411.908378.494405.873434.418468.365428.131369.24355.209337.481308.17257.725227.3220.535197.876172.12154.696154.834166.912156.224158.1158.7172167.7158.5154.2127.597.9157.3
Gross Profit Ratio 0.5170.5260.5090.4570.490.4320.4560.4270.4460.4770.4990.480.5070.5250.5230.5150.4990.5060.5250.5160.4730.4590.4840.5680.5620.560.5550.5550.6030.6040.6210.5890.5551
Reseach & Development Expenses 52.22950.13146.80132.85730.88335.71439.22837.55645.56554.18754.248.64136.80132.65626.37623.85924.32223.88426.51619.99417.79319.51219.51219.03914.92715.117.91918.516.715.8000
General & Administrative Expenses 409.069369.475335.163271.488295.38293.777313.423299.226320.07335.191363.238314.2060000000000000000000000
Selling & Marketing Expenses 7.17.24.42.74.34.53.12.53.94.53.64.60000000000000000000000
SG&A 416.169376.675339.563274.188299.68298.277316.523301.726323.97339.691366.838318.806245.261213.899214.483198.744163.116137.073121.351118.039108.4597.70588.87486.73482.75886.786.992.381.875.775.977.2610
Other Expenses 40.4532.25847.41432.8350.59900-8.09587.6685.4411.711-6.540-1.89413.34100-5.475-26.35-0.10004.61424.90624.622.912.313.113.710.78.570
Operating Expenses 468.398459.064433.778339.875330.563333.991355.751339.282369.535393.878421.038367.447282.062244.661240.859222.603187.438155.482121.517137.933126.243117.217108.386110.387122.591126.4127.7123.6113.4106.1102.485.7680
Operating Income 208.139156.03380.7557.963153.9583.54556.157-19.381-43.98340.5447.32756.43788.758110.54883.28185.56770.28762.74599.01859.94345.87737.47936.44813.4233.63331.73148.454.352.451.841.829.9157.3
Operating Income Ratio 0.1590.1340.0810.0670.1560.0860.062-0.022-0.0480.0450.050.0630.1220.1630.1290.1430.1360.140.2360.1560.1260.1110.1140.0460.1210.1120.1080.1560.1950.20.2090.1930.171
Total Other Income Expenses Net -56.274-14.63-17.12114.95-66.798-9.9128-58.593-80.321-5.441-1.711-6.542.32-0.845-15.009-2.4691.974-0.61529.1680.1260.992.409-7.94-20.188-6.9365.1-2343.222.70.20.60
Income Before Tax 151.865141.40363.62972.91387.15273.63359.632-27.476-53.45731.16536.40149.89789.498110.08181.2785.00277.30272.336106.88259.84145.81238.60738.50517.32627.32532.64.550.755.252.550.84027.70
Income Before Tax Ratio 0.1160.1210.0640.0840.0880.0760.066-0.031-0.0590.0340.0390.0560.1230.1630.1260.1420.150.1610.2550.1560.1260.1150.120.0590.0980.1160.0160.1640.1980.20.2050.1850.1570
Income Tax Expense 34.30726.00220.254-6.55610.62618.61414.06-1.2082.16314.2681.25311.09722.61230.10122.89525.69825.32223.22737.80620.20216.49210.22810.78210.098.47111.43.917.719.318.919.315.29.70
Net Income 117.558115.40143.37579.46976.52655.01945.572-26.268-55.6216.89735.14838.866.88679.9858.37559.30451.9849.10969.07639.63929.3228.37930.0277.23618.99821.1-24.83335.933.631.524.8180
Net Income Ratio 0.090.0990.0440.0910.0770.0570.05-0.03-0.0610.0190.0370.0430.0920.1180.090.0990.1010.1090.1650.1030.080.0840.0940.0250.0680.075-0.0870.1070.1290.1280.1270.1150.1020
EPS 2.322.270.851.571.511.070.86-0.51-1.090.330.680.761.31.591.151.1710.921.290.770.60.570.570.140.30.39-0.470.610.660.610.560.450.330.26
EPS Diluted 2.292.240.841.551.481.040.85-0.51-1.090.320.670.741.31.561.121.140.970.891.250.750.60.560.560.140.290.39-0.470.60.650.590.550.440.320.25
EBITDA 305.354249.34169.471142.25264.239192.963145.404128.945126.37140.5447.32760.68484.858159.07797.021123.99799.5199.9379587.39375.03663.50180.004101.21265.47551.276.956.764.264.159.850.136.3157.3
EBITDA Ratio 0.2330.2130.1710.1630.2670.1990.1610.1460.1390.0450.050.0680.1170.2350.150.2070.1930.2220.2260.2280.2060.1880.250.3440.2360.1810.2690.1830.2310.2440.2410.2320.2061